Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
Striatal dopamine transporters (DAT) powerfully regulate dopamine signaling, and can contribute risk to degeneration in Parkinson’s disease (PD). DATs can interact with the neuronal protein α-synuclein, which is associated with the etiology and molecular pathology of idiopathic and familial PD. Here...
Main Authors: | Sarah Threlfell, Amir Saeid Mohammadi, Brent J. Ryan, Natalie Connor-Robson, Nicola J. Platt, Rishi Anand, Florence Serres, Trevor Sharp, Nora Bengoa-Vergniory, Richard Wade-Martins, Andrew Ewing, Stephanie J. Cragg, Katherine R. Brimblecombe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2021.658244/full |
Similar Items
-
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01) -
GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model
by: Bradley M. Roberts, et al.
Published: (2020-10-01) -
Parkinson Hastalığı ve İlişkili Olduğu Genler
by: Yener Kurman
Published: (2018-01-01) -
The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos
by: S. García, et al.
Published: (2016-06-01) -
α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
by: Hisham Abdelmotilib, et al.
Published: (2017-09-01)